Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ITUS Corp (NASDAQ:ITUS)

2.44
Delayed Data
As of Oct 20
 -0.14 / -5.43%
Today’s Change
0.60
Today|||52-Week Range
6.82
-54.81%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$37.4M

Company Description

ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered in Los Angeles, CA.

Contact Information

ITUS Corp.
12100 Wilshire Boulevard
Los Angeles California 90025
P:(310) 484-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders2.76%
Individual stakeholders11.85%
Other institutional0.63%

Top Executives

Amit KumarChairman, President & Chief Executive Officer
Michael J. CatelaniChief Operating Officer
John A. RoopSenior Vice President-Engineering
Anthony CampisiVice President-Engineering